Listeria monocytogenes Meningitis Following Imatinib Mesylate-Induced Monocytopenia in a Patient with Chronic Myeloid Leukemia
Clicks: 223
ID: 111486
2005
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Imatinib mesylate (Gleevec, Novartis), a selective inhibitor of BCR-ABL tyrosine kinase, has revolutionized the treatment of chronic myeloid leukemia. Patient r| Reference Key |
hélà ne2005clinicallisteria
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ferrand, Hélà ne;Tamburini, Jérôme;Mouly, Stéphane;Bouscary, Didier;Bergmann, Jean-François; |
| Journal | clinical infectious diseases |
| Year | 2005 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.